Skip to main content
Top
Published in: Inflammation 2-3/2005

01-06-2005

Interferon γ-Induced Gene Expression of the Novel Secretory Phospholipase A2 Type IID in Human Monocyte-Derived Macrophages is Inhibited by Lipopolysaccharide

Authors: John Lindbom, Anders G. Ljungman, Christer Tagesson

Published in: Inflammation | Issue 2-3/2005

Login to get access

Abstract

Phospholipase A2 (PLA2) is a superfamily of enzymes that may play a major role in airways inflammation. We investigated the effect of interferon-γ (IFN-γ) on the gene expression of 19 different PLA2 types in human monocyte-derived macrophages and nasal epithelial cells (RPMI 2650). The cells were stimulated with IFN-γ for different lengths of time (up to 48 h), and the mRNA levels of the different PLA2 types were determined by reverse transcriptase–PCR (RT-PCR) and normalized to those of the house-keeping gene, GAPDH. It appeared that IFN-γ clearly increased the expression of secretory PLA2 IID (but not IIA) in macrophages, while both PLA2 IID and IIA were upregulated in RPMI 2650 cells. Moreover, after 18 h, the mRNA levels of cytosolic PLA2 IVA were 2–3 times higher in IFN-γ-stimulated macrophages than controls, while there was no such effect of IFN-γ in RPMI 2650 cells. Lipopolysaccharide (LPS) augmented the increased gene expression of PLA2 IVA but decreased both the basal and the IFN-γ-induced PLA2 IID mRNA expression in macrophages (but not in RPMI 2650 cells). The NF-κB inhibitor Pyrrolidine dithiocarbamate (PDTC) and the phoshatidylinositol 3-kinase (PI3K) inhibitor wortmannin were employed to get an insight into the mechanism behind these observations. Incubation of macrophages with PDTC had no effect on the LPS impairment of PLA2 IID gene expression, but inhibited the LPS mediated activation of PLA2 IVA. No significant effect was noted of PDTC on IFN-γ stimulation, while PI3K had no effect at all on any of the stimuli used. Furthermore, LPS (but not IFN-γ) increased the mRNA levels of the nuclear factor (NF)-κB inhibitors α and ξ in macrophages, but not in RPMI 2650 cells. These findings indicate that (a) the gene expression of secretory types PLA2 IID and IIA in response to IFN-γ is much dependent on cell type, and (b) the regulation of PLA2 type IID in human macrophages is clearly different from that of PLA2 type IVA. (c) PLA2 IVA is probably under control of both NF-κB and IFN-γ-responsive elements (GRE) or IFN-γ-activating sites (GAS). The possibility that PLA2 IID is involved in cytokine-mediated inflammation in the nasal mucosa is inferred, as is the potential role of PLA2 IID in the host defense against LPS-containing bacteria.
Literature
1.
go back to reference Barnes P. J., K. F. Chung, C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev.50:515–596PubMed Barnes P. J., K. F. Chung, C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev.50:515–596PubMed
2.
go back to reference Seilhamer J. J., T. L. Randall, M. Yamanaka, L. K. Johnson. 1986. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 6: 519–527 Seilhamer J. J., T. L. Randall, M. Yamanaka, L. K. Johnson. 1986. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 6: 519–527
3.
go back to reference Seilhamer J. J., W. Pruzanski, P. Vadas, S. Plant, J. A. Miller, J. Kloss, L. K. Johnson. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335–5338PubMed Seilhamer J. J., W. Pruzanski, P. Vadas, S. Plant, J. A. Miller, J. Kloss, L. K. Johnson. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335–5338PubMed
4.
go back to reference Ishizaki J., N. Suzuki, K. Higashino, Y. Yokota, T. Ono, K. Kawamoto, N. Fujii, H. Arita, K. Hanasaki. 1999. Cloning and characterization of novel mouse and human secretory phospholipase A2s. J. Biol. Chem. 274:24973–24979PubMedCrossRef Ishizaki J., N. Suzuki, K. Higashino, Y. Yokota, T. Ono, K. Kawamoto, N. Fujii, H. Arita, K. Hanasaki. 1999. Cloning and characterization of novel mouse and human secretory phospholipase A2s. J. Biol. Chem. 274:24973–24979PubMedCrossRef
5.
go back to reference Suzuki N., J. Ishizaki, Y. Yokota, K. Higashino, T. Ono, M. Ikeda, Fujii N., Kawamoto K., Hanasako K. 2000. Structures, enzymatic properties and expression of novel human and mouse secretory phospholipase A2. J. Biol. Chem. 275:5785–5793PubMedCrossRef Suzuki N., J. Ishizaki, Y. Yokota, K. Higashino, T. Ono, M. Ikeda, Fujii N., Kawamoto K., Hanasako K. 2000. Structures, enzymatic properties and expression of novel human and mouse secretory phospholipase A2. J. Biol. Chem. 275:5785–5793PubMedCrossRef
6.
go back to reference Valentin E., A. G. Singer, F. Ghomashchi, M. Lazdunski, M. H. Gelb, G. Lambeau. 2000. Cloning and recombinant expression of human group IIF-secreted phospholipase A2. Biochem. Biophys. Res. Commun. 279:223–228PubMedCrossRef Valentin E., A. G. Singer, F. Ghomashchi, M. Lazdunski, M. H. Gelb, G. Lambeau. 2000. Cloning and recombinant expression of human group IIF-secreted phospholipase A2. Biochem. Biophys. Res. Commun. 279:223–228PubMedCrossRef
7.
go back to reference Valentin E., F. Ghomashchi, M. Gelb, M. Lazdunski, G. Lambeau. 2000. Novel human secreted phospholipase A2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275:7492–7496PubMedCrossRef Valentin E., F. Ghomashchi, M. Gelb, M. Lazdunski, G. Lambeau. 2000. Novel human secreted phospholipase A2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275:7492–7496PubMedCrossRef
8.
go back to reference Clark J. D., L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–4051PubMedCrossRef Clark J. D., L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–4051PubMedCrossRef
9.
go back to reference Pickard T. R., B. A. Strifler, R. M. Kramer, J. D. Sharp. 1999. Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J. Biol. Chem. 274:8823–8831PubMedCrossRef Pickard T. R., B. A. Strifler, R. M. Kramer, J. D. Sharp. 1999. Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J. Biol. Chem. 274:8823–8831PubMedCrossRef
10.
go back to reference Underwood K. W., C. Song, R. W. Kriz, X. J. Chang, J. L. Knopf, L.-L. Lin. 1998. A novel calcium-independent phospholipase A2, cPLA2-γ, that is prenylated and contains homology to cPLA2. J. Biol. Chem. 273:21926–21932PubMedCrossRef Underwood K. W., C. Song, R. W. Kriz, X. J. Chang, J. L. Knopf, L.-L. Lin. 1998. A novel calcium-independent phospholipase A2, cPLA2-γ, that is prenylated and contains homology to cPLA2. J. Biol. Chem. 273:21926–21932PubMedCrossRef
11.
go back to reference Chen J., S. J. Engle, J. J. Seilhamer, J. A. Tischfield. 1994. Cloning and recombinant expression of a novel human low molecular weight Ca2+-dependent phospholipase A2. J. Biol. Chem. 269:2365–2368PubMed Chen J., S. J. Engle, J. J. Seilhamer, J. A. Tischfield. 1994. Cloning and recombinant expression of a novel human low molecular weight Ca2+-dependent phospholipase A2. J. Biol. Chem. 269:2365–2368PubMed
12.
go back to reference Larsson P. K. A., H. E. Claesson, B. P. Kennedy. 1998. Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J. Biol. Chem. 273: 207–214PubMedCrossRef Larsson P. K. A., H. E. Claesson, B. P. Kennedy. 1998. Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J. Biol. Chem. 273: 207–214PubMedCrossRef
13.
go back to reference Mancuso D. J., C. M. Jenkins, R. W. Gross. 2000. The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A2. J. Biol. Chem. 275: 9937–9945PubMedCrossRef Mancuso D. J., C. M. Jenkins, R. W. Gross. 2000. The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A2. J. Biol. Chem. 275: 9937–9945PubMedCrossRef
14.
go back to reference Tanaka H., R. Takeya, H. Sumimoto. 2000. A novel intracellular membrane-bound calcium-independent phospholipase A2. Biochem. Biophys. Res. Commun. 272:320–326PubMedCrossRef Tanaka H., R. Takeya, H. Sumimoto. 2000. A novel intracellular membrane-bound calcium-independent phospholipase A2. Biochem. Biophys. Res. Commun. 272:320–326PubMedCrossRef
15.
go back to reference Tjoelker L., C. Wilder, C. Eberhardt, D. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Trong, L. Cousens, G. Zimmerman, Y. Yamada, T. McIntyre, S. Prescott, P. Gray. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549–553PubMedCrossRef Tjoelker L., C. Wilder, C. Eberhardt, D. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Trong, L. Cousens, G. Zimmerman, Y. Yamada, T. McIntyre, S. Prescott, P. Gray. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549–553PubMedCrossRef
16.
go back to reference Tew D., C. Southan, S. Rice, M. Lawrence, H. Li, H. Boyd, K. Moores, I. Gloger, C. Macphee. 1996. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16:591–599PubMed Tew D., C. Southan, S. Rice, M. Lawrence, H. Li, H. Boyd, K. Moores, I. Gloger, C. Macphee. 1996. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16:591–599PubMed
17.
go back to reference Hattori K., H. Adachi, A. Matsuzawa, K. Yamomoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, K. Inoue. 1996. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. J. Biol. Chem. 271:33032–33038PubMedCrossRef Hattori K., H. Adachi, A. Matsuzawa, K. Yamomoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, K. Inoue. 1996. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. J. Biol. Chem. 271:33032–33038PubMedCrossRef
18.
go back to reference Adachi H., M. Tsjuimoto, M. Hattori, H. Arai, K. Inoue. 1995. cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase γ-subunit and its mRNA expression in human tissues. Biochem. Biophys. Res. Com. 214:180–187PubMedCrossRef Adachi H., M. Tsjuimoto, M. Hattori, H. Arai, K. Inoue. 1995. cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase γ-subunit and its mRNA expression in human tissues. Biochem. Biophys. Res. Com. 214:180–187PubMedCrossRef
19.
go back to reference Adachi H., M. Tsujimoto, M. Hattori, H. Arai, K. Inoue. 1997. Differential tissue distribution of the β- and γ-subunits of human cytosolic platelet-activating factor acetylhydrolase (isoform I). Biochem. Biophys. Res. Com. 233:10–13PubMedCrossRef Adachi H., M. Tsujimoto, M. Hattori, H. Arai, K. Inoue. 1997. Differential tissue distribution of the β- and γ-subunits of human cytosolic platelet-activating factor acetylhydrolase (isoform I). Biochem. Biophys. Res. Com. 233:10–13PubMedCrossRef
20.
go back to reference Cupillard L., K. Koumanov, M. G. Mattéi, M. Lazdunski, G. Lambeau. 1997. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J. Biol. Chem. 272:15745–15752PubMedCrossRef Cupillard L., K. Koumanov, M. G. Mattéi, M. Lazdunski, G. Lambeau. 1997. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J. Biol. Chem. 272:15745–15752PubMedCrossRef
21.
go back to reference Gelb M. H., E. Valentin, F. Ghomaschi, M. Lazdunski, G. Lambeau. 2000. Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J. Biol. Chem. 275:39823–39826PubMedCrossRef Gelb M. H., E. Valentin, F. Ghomaschi, M. Lazdunski, G. Lambeau. 2000. Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J. Biol. Chem. 275:39823–39826PubMedCrossRef
22.
go back to reference Rouault M., J. G. Bollinger, M. Lazdunski, M. H. Gelb, G. Lambeau. 2003. Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. Biochemistry 42: 11494–11503PubMedCrossRef Rouault M., J. G. Bollinger, M. Lazdunski, M. H. Gelb, G. Lambeau. 2003. Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. Biochemistry 42: 11494–11503PubMedCrossRef
23.
go back to reference Dennis E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1–2PubMedCrossRef Dennis E. A. 1997. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1–2PubMedCrossRef
24.
go back to reference Balsinde J., M. A. Balboa, P. A. Insel, E. A. Dennis. 1999. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39:175–189PubMedCrossRef Balsinde J., M. A. Balboa, P. A. Insel, E. A. Dennis. 1999. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39:175–189PubMedCrossRef
25.
go back to reference Wu T., S. J. Levine, M. Cowan, C. Logun, W. C. Angus, J. H. Shelhamer. 1997. Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells. Am. J. Physiol. 273:L331–L338PubMed Wu T., S. J. Levine, M. Cowan, C. Logun, W. C. Angus, J. H. Shelhamer. 1997. Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells. Am. J. Physiol. 273:L331–L338PubMed
26.
go back to reference Wu T., S. J. Levine, M. G. Lawrence, C. Logun, W. Angus, J. H. Shelhamer. 1994. Interferon-γ induces the synthesis and activation of cytosolic phospholipase A2. J. Clin. Invest. 93:571–577PubMedCrossRef Wu T., S. J. Levine, M. G. Lawrence, C. Logun, W. Angus, J. H. Shelhamer. 1994. Interferon-γ induces the synthesis and activation of cytosolic phospholipase A2. J. Clin. Invest. 93:571–577PubMedCrossRef
27.
go back to reference Kaiser E. 1999. Phospholipase A2: its usefulness in laboratory diagnostics. Crit. Rev. Clin. Lab. Sci. 36:65–163PubMedCrossRef Kaiser E. 1999. Phospholipase A2: its usefulness in laboratory diagnostics. Crit. Rev. Clin. Lab. Sci. 36:65–163PubMedCrossRef
28.
go back to reference Peilot H., B. Rosengren, G. Bondjers, E. Hurt-Camejo. 2000. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J. Biol. Chem. 275:22895–22904PubMedCrossRef Peilot H., B. Rosengren, G. Bondjers, E. Hurt-Camejo. 2000. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J. Biol. Chem. 275:22895–22904PubMedCrossRef
29.
go back to reference Lindbom J., A. G. Ljungman, M. Lindahl, C. Tagesson. 2002. Increased gene expression of novel cytosolic and secretory phospholipase A2 types in human airway epithelial cells induced by tumor necrosis factor-α and IFN-γ. J. Interferon. Cytokine. Res. 22:947–955PubMedCrossRef Lindbom J., A. G. Ljungman, M. Lindahl, C. Tagesson. 2002. Increased gene expression of novel cytosolic and secretory phospholipase A2 types in human airway epithelial cells induced by tumor necrosis factor-α and IFN-γ. J. Interferon. Cytokine. Res. 22:947–955PubMedCrossRef
31.
go back to reference Lindbom J., A. G. Ljungman, M. Lindahl, C. Tagesson. 2001. Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa. Eur. Respir. J. 18:130–138PubMedCrossRef Lindbom J., A. G. Ljungman, M. Lindahl, C. Tagesson. 2001. Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa. Eur. Respir. J. 18:130–138PubMedCrossRef
32.
go back to reference Gantner F., R. Kupferschmidt, C. Schudt, A. Wendel, A. Hatzelmann. 1997. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br. J. Pharmacol. 121:221–231PubMedCrossRef Gantner F., R. Kupferschmidt, C. Schudt, A. Wendel, A. Hatzelmann. 1997. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br. J. Pharmacol. 121:221–231PubMedCrossRef
33.
go back to reference Hammerstrom J. 1979. Human macrophage differentiation in vivo and in vitro. A comparison of human peritoneal macrophages and monocytes. Acta Pathol. Microbiol. Scand. C. 87: 113–120 Hammerstrom J. 1979. Human macrophage differentiation in vivo and in vitro. A comparison of human peritoneal macrophages and monocytes. Acta Pathol. Microbiol. Scand. C. 87: 113–120
34.
go back to reference Nii A., S. Sone, E. Orino, T. Ogura. 1993. Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophages. J. Leukoc. Biol. 53:29–36PubMed Nii A., S. Sone, E. Orino, T. Ogura. 1993. Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophages. J. Leukoc. Biol. 53:29–36PubMed
35.
go back to reference Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698–2707PubMedCrossRef Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698–2707PubMedCrossRef
36.
go back to reference Siebenlist U., G. Franzoso, K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405–455PubMedCrossRef Siebenlist U., G. Franzoso, K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405–455PubMedCrossRef
37.
go back to reference Kumar A., J. Haque, J. Lacoste, J. Hiscott, B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. U.S.A. 91:6288–6292PubMedCrossRef Kumar A., J. Haque, J. Lacoste, J. Hiscott, B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. U.S.A. 91:6288–6292PubMedCrossRef
38.
go back to reference Velasco M., M. J. Diaz-Guerra, P. Martin-Sanz, A. Alvarez, L. Bosca. 1997. Rapid up-regulation of IkappaBbeta and abrogation of NF-kappaB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025–23030PubMedCrossRef Velasco M., M. J. Diaz-Guerra, P. Martin-Sanz, A. Alvarez, L. Bosca. 1997. Rapid up-regulation of IkappaBbeta and abrogation of NF-kappaB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025–23030PubMedCrossRef
39.
go back to reference Yamazaki S., T. Muta, K. Takeshige. 2001. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276:27657–27662PubMedCrossRef Yamazaki S., T. Muta, K. Takeshige. 2001. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276:27657–27662PubMedCrossRef
40.
go back to reference Muta T., S. Yamazaki, A. Eto, M. Motoyama, K. Takeshige. 2003. IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB. J. Endotoxin. Res. 9:187–191PubMedCrossRef Muta T., S. Yamazaki, A. Eto, M. Motoyama, K. Takeshige. 2003. IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB. J. Endotoxin. Res. 9:187–191PubMedCrossRef
41.
go back to reference Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698–2707PubMedCrossRef Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698–2707PubMedCrossRef
42.
go back to reference Murakami M., R. S. Koduri, A. Enomoto, S. Shimbara, M. Seki, K. Yoshihara, A. Singer, E. Valentin, F. Ghomashchi, G. Lambeau, M. H. Gelb, I. Kudo. 2001. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:10083–10096PubMedCrossRef Murakami M., R. S. Koduri, A. Enomoto, S. Shimbara, M. Seki, K. Yoshihara, A. Singer, E. Valentin, F. Ghomashchi, G. Lambeau, M. H. Gelb, I. Kudo. 2001. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:10083–10096PubMedCrossRef
43.
go back to reference Seeds M. C., D. L. Bowton, R. D. Hite, J. I. Gyves, D. A. Gyves. 2003. Human eosinophil group IID secretory phospholipase A2 causes surfactant dysfunction. Chest 123:376S–377SPubMedCrossRef Seeds M. C., D. L. Bowton, R. D. Hite, J. I. Gyves, D. A. Gyves. 2003. Human eosinophil group IID secretory phospholipase A2 causes surfactant dysfunction. Chest 123:376S–377SPubMedCrossRef
44.
go back to reference Koduri R. S., J. O. Gronroos, V. J. Laine, C. Le Calvez, G. Lambeau, T. J. Nevalainen, M. H. Gelb. 2002. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 277:5849–5857PubMedCrossRef Koduri R. S., J. O. Gronroos, V. J. Laine, C. Le Calvez, G. Lambeau, T. J. Nevalainen, M. H. Gelb. 2002. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 277:5849–5857PubMedCrossRef
45.
go back to reference Schreck R., B. Meier, D. N. Mannel, W. Droge, P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181–1194PubMedCrossRef Schreck R., B. Meier, D. N. Mannel, W. Droge, P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181–1194PubMedCrossRef
46.
go back to reference Schreck R., R. Grassmann, B. Fleckenstein, P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288–6293PubMed Schreck R., R. Grassmann, B. Fleckenstein, P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288–6293PubMed
47.
go back to reference Guha M., N. Mackman. 2002. The phosphatidylinositol 3-kinase–Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124–32132PubMedCrossRef Guha M., N. Mackman. 2002. The phosphatidylinositol 3-kinase–Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124–32132PubMedCrossRef
48.
go back to reference Rosenberger C. M., B. B. Finlay. 2003. Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat. Rev., Mol. Cell Biol. 4:385–396CrossRef Rosenberger C. M., B. B. Finlay. 2003. Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat. Rev., Mol. Cell Biol. 4:385–396CrossRef
49.
go back to reference Wu T., T. Ikezono, C. W. Angus, J. H. Shelhamer. 1994. Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res. 22:5093–5098PubMed Wu T., T. Ikezono, C. W. Angus, J. H. Shelhamer. 1994. Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res. 22:5093–5098PubMed
50.
go back to reference Morri H., M. Ozaki, Y. Watanabe. 1994. 5′-Flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem. Biophys. Res. Commun. 205:6–11PubMedCrossRef Morri H., M. Ozaki, Y. Watanabe. 1994. 5′-Flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem. Biophys. Res. Commun. 205:6–11PubMedCrossRef
51.
go back to reference Ikezono T., T. Wu, X. L. Yao, S. Levine, C. Logun, W. C. Angus, J. H. Shelhamer. 1997. Leukemia inhibitory factor induces the 85-kDa cytosolic phospholipase A2 gene expression in cultured human bronchial epithelial cells. Biochim. Biophys. Acta 1355:121–130PubMedCrossRef Ikezono T., T. Wu, X. L. Yao, S. Levine, C. Logun, W. C. Angus, J. H. Shelhamer. 1997. Leukemia inhibitory factor induces the 85-kDa cytosolic phospholipase A2 gene expression in cultured human bronchial epithelial cells. Biochim. Biophys. Acta 1355:121–130PubMedCrossRef
52.
go back to reference Dolan-O'Keefe M., V. Chow, J. Monnier, G. A. Visner, H. S. Nick. 2000. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L649–L657PubMed Dolan-O'Keefe M., V. Chow, J. Monnier, G. A. Visner, H. S. Nick. 2000. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L649–L657PubMed
53.
go back to reference Blaine S. A., M. Wick, C. Dessev, R. A. Nemenoff. 2001. Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J. Biol. Chem. 276:42737–42743PubMedCrossRef Blaine S. A., M. Wick, C. Dessev, R. A. Nemenoff. 2001. Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J. Biol. Chem. 276:42737–42743PubMedCrossRef
54.
go back to reference Gutcher I., P. R. Webb, N. G. Anderson. 2003. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol. Life Sci. 60:1061–1070PubMed Gutcher I., P. R. Webb, N. G. Anderson. 2003. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol. Life Sci. 60:1061–1070PubMed
55.
go back to reference Matte C., G. Maion, W. Maurad, M. Olivier. 2001. Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis. Parasite Immunol. 23:177–184PubMedCrossRef Matte C., G. Maion, W. Maurad, M. Olivier. 2001. Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis. Parasite Immunol. 23:177–184PubMedCrossRef
56.
go back to reference Rao K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3–10PubMed Rao K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3–10PubMed
57.
go back to reference Wright S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433PubMed Wright S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433PubMed
58.
go back to reference Hoshino K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:3749–3752PubMed Hoshino K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:3749–3752PubMed
59.
go back to reference Andreani M., J. L. Olivier, F. Berenbaum, M. Raymondjean, G. Bereziat. 2000. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim. Biophys. Acta 1488: 149–158PubMed Andreani M., J. L. Olivier, F. Berenbaum, M. Raymondjean, G. Bereziat. 2000. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim. Biophys. Acta 1488: 149–158PubMed
60.
go back to reference Roy S. K., S. J. Wachira, X. Weihua, J. Hu, D. V. Kalvakolanu. 2000. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275:12626–12632PubMedCrossRef Roy S. K., S. J. Wachira, X. Weihua, J. Hu, D. V. Kalvakolanu. 2000. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275:12626–12632PubMedCrossRef
61.
go back to reference Salmenpera P., S. Hamalainen, M. Hukkanen, E. Kankuri. 2003. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am. J. Physiol. Cell Physiol. 284:C1133–C1139PubMed Salmenpera P., S. Hamalainen, M. Hukkanen, E. Kankuri. 2003. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am. J. Physiol. Cell Physiol. 284:C1133–C1139PubMed
62.
go back to reference Gillies S. D., S. L. Morrison, V. T. Oi, S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717–728PubMedCrossRef Gillies S. D., S. L. Morrison, V. T. Oi, S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717–728PubMedCrossRef
Metadata
Title
Interferon γ-Induced Gene Expression of the Novel Secretory Phospholipase A2 Type IID in Human Monocyte-Derived Macrophages is Inhibited by Lipopolysaccharide
Authors
John Lindbom
Anders G. Ljungman
Christer Tagesson
Publication date
01-06-2005
Published in
Inflammation / Issue 2-3/2005
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9007-x

Other articles of this Issue 2-3/2005

Inflammation 2-3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine